Curanex Pharmaceuticals Inc
NASDAQ:CURX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Curanex Pharmaceuticals Inc
NASDAQ:CURX
|
US |
Balance Sheet
Balance Sheet Decomposition
Curanex Pharmaceuticals Inc
Curanex Pharmaceuticals Inc
Balance Sheet
Curanex Pharmaceuticals Inc
| Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|
| Assets | ||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
1
|
|
| Total Assets |
0
N/A
|
0
+629%
|
1
+596%
|
|
| Liabilities | ||||
| Accounts Payable |
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
|
| Long-Term Debt |
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
N/A
|
0
+2%
|
|
| Equity | ||||
| Common Stock |
0
|
0
|
0
|
|
| Retained Earnings |
0
|
0
|
1
|
|
| Additional Paid In Capital |
0
|
0
|
1
|
|
| Total Equity |
0
N/A
|
0
+489%
|
1
+738%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
+629%
|
1
+596%
|
|
| Shares Outstanding | ||||
| Common Shares Outstanding |
28
|
28
|
28
|
|